KCNJ10 and myeloid sarcoma: They mentioned that the pathologic mechanisms remain unclear as to how MS patients generate autoantibodies against KiR4.1, and how these antibodies induce pathogenic effects on demyelinated axons through the defective transport of potassium, glutamate and water.